Expanding Research Horizons: CD Formulation Unveils its Redesigned Collection of Pharmaceutical Excipients

October 15, 2023

Since its launch, the pharmaceutical excipients provided by CD Formulation have gained significant popularity among customers worldwide. To enhance the search process, CD Formulation has recently reorganized its collection of pharmaceutical excipients and unveiled these changes on its website. With a focus on improving drug delivery systems and dosage forms, the company aims to offer innovative solutions to the pharmaceutical industry.

 

Pharmaceutical excipients are inactive substances combined with active pharmaceutical ingredients (APIs) to create final drug products. These excipients play a crucial role in ensuring the stability, effectiveness, and safety of medications, as well as improving their palatability and appearance.

 

“Our new collection of pharmaceutical excipients covers a wide range of dosage forms, including liquids, solids, semi-solids, controlled-release, transdermal, mucosal, and micro drug delivery systems. Each formulation is meticulously designed to meet the unique needs of different medications and patient populations,” said the Marketing Director of CD Formulation.

 

Excipients for Liquid Dosage Form

Liquid preparations are currently the most widely used in clinical practice. In the realm of liquid dosage forms, CD Formulation offers a variety of excipients to enhance solubility, stability, and bioavailability of active ingredients. These include favoring agents, dispersion excipients, solubilizer excipients, surfactants, suspending agents, effervescents, emulsifiers, wetting agents, and preservatives.

 

Excipients for Injections & Sterile Formulation

For injections and sterile formulations, CD Formulation provides excipients that maintain the sterility and stability of parenteral products. Commonly used excipients for injections and sterile formulations mainly include antioxidants, chelating agents, emulsifiers, suspending agents, lyophilization reagents, osmotic pressure regulators, ph modifiers, solubilizers, and preservatives.

 

Excipients for Solid and Semi-solid Dosage Forms

By utilizing advanced technologies, CD Formulation offers a wide range of solid and semi-solid excipients, including binders, capsule excipients, coating system excipients, disintegrants, fillers, colorants, plasticizers, film formers, sweeteners, inclusion compounds, lubricants, wetting agents, cooling agents, drop pill bases, ointment bases, plasters bases, and suppository bases.

 

Excipients for Sustained & Controlled Release Materials

CD Formulation also offers controlled-release excipients that enable sustained and controlled drug release. Some of these excipients are listed here: polyethylene glycol (MW:400), polyethylene glycol (MW:4000), polyethylene glycol (MW:6000), polyacrylic acid, polyethylene oxide, poly (lactic co-glycolic acid), polylactic acid, polyethylene glycol, PVA, silicone elastomer, stearic acid, cellulose acetate, and more.

 

Excipients for Transdermal and Mucosal Drug Delivery Systems Materials

In addition to traditional drug delivery systems, CD Formulation leads in developing materials for transdermal and mucosal drug delivery systems. These advanced materials can enhance drug absorption and bioavailability through the skin and mucous membranes, offering an alternative route of administration for certain medications. CD Formulation’s offerings include ethylene-vinyl acetate copolymer, polypropylene, PVA, polysiloxanes, polyvinyl chloride, dimethyl sulfoxide, oleic acid, lauric acid, carboxymethylcellulose sodium, carbomer 934, and disodium edetate.

 

Excipients for Micro-drug Delivery Systems Materials

Furthermore, CD Formulation provides a series of excipients for micro-drug delivery systems, including emulsifiers and other materials. Micro-drug delivery systems utilize innovative technologies and materials to deliver precise medication doses to targeted body sites, improving efficacy and reducing side effects, especially in localized drug delivery therapies.

 

“In general, the reorganized collection of pharmaceutical excipients marks a significant milestone in our company's commitment to providing cutting-edge solutions to the pharmaceutical industry. By offering a wide range of specialized excipients, we aim to support the development of safe, effective, and patient-friendly medications,” the Marketing Director added.

 

For more information, please visit https://www.formulationbio.com/products/pharmaceutical-excipients.html.

 

About CD Formulation

Combining robust expertise and years of experience, CD Formulation is an ideal partner for drug developers needing to overcome formulation and delivery challenges. Recently, the company has prioritized its role as a supplier of APIs and pharmaceutical excipients to ensure meeting the highest quality standards.